Flourish Lands $500 Million to Revolutionize AI with Neuroscience Research

By Patricia Miller

Jun 04, 2026

1 min read

Flourish raises $500 million to advance AI using neurological research, promising a significant shift in technology.

Flourish, a New York startup, has secured $500 million in funding and achieved a $2.5 billion valuation, with notable backing from Jeff Bezos among others. The company promotes a groundbreaking approach by shifting from theoretical models of brain function to actual neurological research. This initiative is encapsulated in their development of Cortex AI, which is focused on mimicking brain function through connectomics, the study of neural connections.

Cortex AI aims to operate efficiently within the power range of 20 to 50 watts, a remarkable feat that would place it on par with conventional laptops as opposed to power-hungry server setups. Achieving this goal would mark a significant leap in AI hardware technology. Currently, Flourish does not have a market-ready product. Instead, the valuation of $2.5 billion, potentially rising to $3.5 billion, largely reflects the founders' credentials and investor confidence in neuroscience-based AI as the next major evolution in technology.

The founders of Flourish include Thomas Reardon and Rob Williams. Reardon gained recognition for developing Internet Explorer at Microsoft and has since led significant advancements in brain-computer interfaces. Williams previously held an executive position at Amazon, further enhancing the company’s leadership profile. Flourish's recent fundraising is its first public milestone, as discussions began in late April 2026 and quickly culminated in this major funding round by early June.

Important Notice And Disclaimer

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.